Does RITUXIMAB-PVVR Cause Interstitial lung disease? 42 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Interstitial lung disease have been filed in association with RITUXIMAB-PVVR. This represents 1.0% of all adverse event reports for RITUXIMAB-PVVR.
42
Reports of Interstitial lung disease with RITUXIMAB-PVVR
1.0%
of all RITUXIMAB-PVVR reports
5
Deaths
13
Hospitalizations
How Dangerous Is Interstitial lung disease From RITUXIMAB-PVVR?
Of the 42 reports, 5 (11.9%) resulted in death, 13 (31.0%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-PVVR. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-PVVR Cause?
Off label use (2,079)
Intentional product use issue (627)
Condition aggravated (514)
Death (338)
Covid-19 (322)
Fatigue (318)
Dyspnoea (314)
Inappropriate schedule of product administration (311)
Headache (291)
Pruritus (288)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RITUXIMAB-PVVR Alternatives Have Lower Interstitial lung disease Risk?
RITUXIMAB-PVVR vs RIVAROXABAN
RITUXIMAB-PVVR vs RIVASTIGMINE
RITUXIMAB-PVVR vs RIVOTRIL
RITUXIMAB-PVVR vs RIZATRIPTAN
RITUXIMAB-PVVR vs ROACTEMRA